Studying Biomarkers and Outcomes in People With High Blood Pressure
Follows adults with high blood pressure to study biomarkers linked to later health problems.
Plain-language title generated from the registry record
Registry title: A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
Key facts
- Where
- Guangzhou, ChinaSee the 2 sites
Where in China
- Guangdong Cardiovascular InstituteGuangzhou, ChinaTaking people
- Guangdong Provincial People's HospitalGuangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Guangdong Provincial People's Hospital
- Trial code
- NCT04212455
- Record updated
- 13 January 2020
- Original description
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.Read full original descriptionShow less
Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.
Inclusion: ≥18 years old; In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension).
Exclusion: <18 years old; Unsigned informed consent; Pregnant Women and Lactation.